Vivo C - Search Results

1

Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection.

Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Demidenko ZN, et al. Among authors: vivo c. Cell Death Differ. 2006 Sep;13(9):1434-41. doi: 10.1038/sj.cdd.4401812. Epub 2005 Nov 25. Cell Death Differ. 2006. PMID: 16311509

2

p21 (CDKN1A) is a negative regulator of p53 stability.

Broude EV, Demidenko ZN, Vivo C, Swift ME, Davis BM, Blagosklonny MV, Roninson IB. Broude EV, et al. Among authors: vivo c. Cell Cycle. 2007 Jun 15;6(12):1468-71. Epub 2007 Apr 12. Cell Cycle. 2007. PMID: 17585201

3

p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.

Broude EV, Swift ME, Vivo C, Chang BD, Davis BM, Kalurupalle S, Blagosklonny MV, Roninson IB. Broude EV, et al. Among authors: vivo c. Oncogene. 2007 Oct 18;26(48):6954-8. doi: 10.1038/sj.onc.1210516. Epub 2007 May 7. Oncogene. 2007. PMID: 17486059

4

Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.

Vivo C, Lévy F, Pilatte Y, Fleury-Feith J, Chrétien P, Monnet I, Kheuang L, Jaurand MC. Vivo C, et al. Oncogene. 2001 Mar 1;20(9):1085-93. doi: 10.1038/sj.onc.1204199. Oncogene. 2001. PMID: 11314045

5

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation.

Vivo C, Lecomte C, Levy F, Leroy K, Kirova Y, Renier A, Kheuang L, Piedbois P, Chopin D, Jaurand MC. Vivo C, et al. Br J Cancer. 2003 Feb 10;88(3):388-95. doi: 10.1038/sj.bjc.6600736. Br J Cancer. 2003. PMID: 12569381 Free PMC article.

6

Analysis of cell cycle disruptions in cultures of rat pleural mesothelial cells exposed to asbestos fibers.

Levresse V, Renier A, Fleury-Feith J, Levy F, Moritz S, Vivo C, Pilatte Y, Jaurand MC. Levresse V, et al. Among authors: vivo c. Am J Respir Cell Mol Biol. 1997 Dec;17(6):660-71. doi: 10.1165/ajrcmb.17.6.2854. Am J Respir Cell Mol Biol. 1997. PMID: 9409553

7

Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma.

Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC. Buard A, et al. Among authors: vivo c. Cancer Res. 1998 Feb 15;58(4):840-7. Cancer Res. 1998. PMID: 9485044

8

Absence of SV40 large T-antigen expression in human mesothelioma cell lines.

Pilatte Y, Vivo C, Renier A, Kheuang L, Greffard A, Jaurand MC. Pilatte Y, et al. Among authors: vivo c. Am J Respir Cell Mol Biol. 2000 Dec;23(6):788-93. doi: 10.1165/ajrcmb.23.6.4251. Am J Respir Cell Mol Biol. 2000. PMID: 11104732

9

Gene expression profiles in human mesothelioma cell lines in response to interferon-gamma treatment.

Kettunen E, Vivo C, Gattacceca F, Knuutila S, Jaurand MC. Kettunen E, et al. Among authors: vivo c. Cancer Genet Cytogenet. 2004 Jul 1;152(1):42-51. doi: 10.1016/j.cancergencyto.2003.10.006. Cancer Genet Cytogenet. 2004. PMID: 15193440

10

c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.

Vivo C, Liu W, Broaddus VC. Vivo C, et al. J Biol Chem. 2003 Jul 11;278(28):25461-7. doi: 10.1074/jbc.M302161200. Epub 2003 Apr 21. J Biol Chem. 2003. PMID: 12707267 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters